# A Study for Participants With Major Depression

> **NCT00420004** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 469 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** LY2216684
- **DRUG:** Placebo
- **DRUG:** Escitalopram

## Key facts

- **NCT ID:** NCT00420004
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 469 (ACTUAL)
- **Last updated:** 2018-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00420004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00420004, "A Study for Participants With Major Depression". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00420004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*